|
Immunotherapy
|
|
1
|
2466
|
September 28, 2016
|
|
Wound Complications
|
|
0
|
2233
|
September 17, 2016
|
|
TBI-1301 (NY-ESO-1 targeting T-cell Trial)
|
|
3
|
2986
|
August 24, 2016
|
|
Cabozantinib
|
|
4
|
3152
|
August 22, 2016
|
|
Mithramycin
|
|
0
|
2357
|
August 9, 2016
|
|
In Vivo Lung Perfusion (IVLP) for Pulmonary Mets
|
|
0
|
2362
|
August 9, 2016
|
|
MEDI4736 and Tremelimumab
|
|
0
|
2509
|
July 9, 2016
|
|
Olaparib and Temozolomide
|
|
0
|
2354
|
July 2, 2016
|
|
Dexrazoxane + Doxorubicin
|
|
0
|
2343
|
February 29, 2016
|
|
Sapanisertib vs Votrient
|
|
0
|
2222
|
February 1, 2016
|
|
T Cell Immunotherapy for Synovial Sarcoma
|
|
1
|
2258
|
December 8, 2015
|
|
Trials for Newly Diagnosed
|
|
0
|
2248
|
September 25, 2015
|
|
Src Inhibitors
|
|
0
|
2204
|
September 25, 2015
|
|
Cryoablation, RFA, Microwave Ablation Trial
|
|
1
|
2216
|
September 15, 2015
|
|
Li-Fraumeni Syndrome
|
|
0
|
2130
|
September 11, 2015
|
|
A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors
|
|
2
|
2180
|
August 3, 2015
|
|
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
|
|
0
|
2128
|
July 30, 2015
|
|
Does anybody know of a MK-3475 (pembrolizumab) trial where you can have more than 3 previous treatments?
|
|
4
|
2351
|
July 7, 2015
|
|
Dendritic Vaccine Trial in Miami
|
|
0
|
2104
|
July 5, 2015
|
|
Oncolytic Virus HSV1716 Trial
|
|
0
|
2026
|
July 5, 2015
|
|
TH302 Clinical Trial
|
|
0
|
2087
|
July 5, 2015
|
|
Pneumothorax and Votrient
|
|
0
|
2098
|
June 28, 2015
|
|
Epz-6438 (e7438)
|
|
0
|
2192
|
June 28, 2015
|
|
Combining Radiotherapy With Targeted Therapy
|
|
0
|
2044
|
June 28, 2015
|
|
Intradermal ID-LV305 Clinical Trial
|
|
0
|
2102
|
June 28, 2015
|
|
Combination fo Vorinostat and Ridaforolimus to Treat Synovial Sarcoma?
|
|
0
|
2068
|
June 28, 2015
|
|
Expression of CXCR4 and IGF-1R in Synovial Sarcoma
|
|
0
|
2093
|
June 28, 2015
|
|
What Could Explain Late Reccurences/Metastases?
|
|
0
|
2011
|
June 28, 2015
|
|
Oligometastasis
|
|
0
|
1986
|
June 28, 2015
|
|
MLN0128, a mTOR inhibitor
|
|
0
|
2027
|
June 28, 2015
|